Divya Lenkala
Seminars
Tuesday 11th November 2025
Overcoming Scale-Up Challenges to Ensure Preparation for Commercial Scale
1:30 pm
This session explores how artificial intelligence is transforming both the analytical and operational aspects of TIL therapy development. From designing clinically meaningful potency assays to navigating the complexities of scaling up manufacturing, experts will share insights on leveraging AI to accelerate progress and ensure commercial readiness.
Thursday 13th November 2025
Advancing Potency Assays for TIL Therapies to Prevent Clinical Holds & Streamline Route to Patients
3:30 pm
- Comparing the development of potency assays for CAR-Ts, TCR-Ts, ex vivo T-cell therapies and TILs, highlighting the unique challenges faced by personalized T-cell therapies like TILs
- Exploring the complexities of developing potency assays for TIL therapies, including surrogate assays and GMP-ready validation
- Discussing the difficulties in validating potency assays that accurately target the mechanism of action of TILs
